The effect of statin treatment on inflammation in patients with metabolic syndrome


Aydin M., Onuk T., DOĞAN S. M., Yildirim N., Demirci E., Kalaycioglu E., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.37, sa.1, ss.26-34, 2009 (ESCI, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 1
  • Basım Tarihi: 2009
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.26-34
  • Anahtar Kelimeler: Anticholesteremic agents/therapeutic use, antigens, biological markers, blood platelets, cell adhesion molecules, flow cytometry, leukocytes, metabolic syndrome X, monocytes, C-REACTIVE PROTEIN, HIGH CARDIOVASCULAR RISK, INSULIN-RESISTANCE, ENDOTHELIAL MICROPARTICLES, CORONARY EVENTS, CHOLESTEROL, PREVENTION, ADHESION, PIOGLITAZONE, SIMVASTATIN
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective: Inflammation plays an important role in the pathogenesis of metabolic syndrome (MS). We investigated the effect of fluvastatin treatment on inflammatory markers in patients with MS.